Next Article in Journal
Does Adjuvant Radiation Therapy Benefit Women with Small Mammography-Detected Breast Cancers?
Previous Article in Journal
Rate of Egfr Mutation Testing for Patients with Nonsquamous Non-Small-Cell Lung Cancer with Implementation of Reflex Testing by Pathologists
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on as a courtesy and upon agreement with Multimed Inc..
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

The Hospital at Home Program: No Place Like Home

Hematology, Oncology, Blood and Marrow Transplant Program, Alberta Children’s Hospital, Calgary, AB, Canada
Author to whom correspondence should be addressed.
Curr. Oncol. 2017, 24(1), 23-27;
Received: 15 October 2016 / Revised: 13 November 2016 / Accepted: 11 December 2016 / Published: 1 February 2017


Background: The treatment of children with cancer is associated with significant burden for the entire family. Frequent clinic visits and extended hospital stays can negatively affect quality of life for children and their families. Methods: Here, we describe the development of a Hospital at Home program (H@H) that delivers therapy to pediatric hematology, oncology, and blood and marrow transplant (bmt) patients in their homes. The services provided include short infusions of chemotherapy, supportive-care interventions, antibiotics, post-chemotherapy hydration, and teaching. Results: From 2013 to 2015, the H@H program served 136 patients, making 1701 home visits, for patients mainly between the ages of 1 and 4 years. Referrals came from oncology in 82% of cases, from hematology in 11%, and from bmt in 7%. Since inception of the program, no adverse events have been reported. Family surveys suggested less disruption in daily routines and appreciation of specialized care by hematology and oncology nurses. Staff surveys highlighted a perceived benefit of H@H in contributing to early discharge of patients by supporting out-of-hospital monitoring and teaching. Conclusions: The development of a H@H program dedicated to the pediatric hematology, oncology, or bmt patient appears feasible. Our pilot program offers a potential contribution to improvement in patient quality of life and in cost–benefit for parents and the health care system.
Keywords: pediatrics; hematology; chemotherapy; program development; home care pediatrics; hematology; chemotherapy; program development; home care

Share and Cite

MDPI and ACS Style

Lippert, M.; Semmens, S.; Tacey, L.; Rent, T.; Defoe, K.; Bucsis, M.; Shykula, T.; Crysdale, J.; Lewis, V.; Strother, D.; et al. The Hospital at Home Program: No Place Like Home. Curr. Oncol. 2017, 24, 23-27.

AMA Style

Lippert M, Semmens S, Tacey L, Rent T, Defoe K, Bucsis M, Shykula T, Crysdale J, Lewis V, Strother D, et al. The Hospital at Home Program: No Place Like Home. Current Oncology. 2017; 24(1):23-27.

Chicago/Turabian Style

Lippert, M., S. Semmens, L. Tacey, T. Rent, K. Defoe, M. Bucsis, T. Shykula, J. Crysdale, V. Lewis, D. Strother, and et al. 2017. "The Hospital at Home Program: No Place Like Home" Current Oncology 24, no. 1: 23-27.

Article Metrics

Back to TopTop